The oncogene and Polycombgroup gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

Nature

Volumn 397, Issue 6715, 1999, Pages 164-168

  Jacobs, Jacqueline L ^a   Kieboom, Karin ^a   Marino, Silvia ^a   DePinho, Ronald A ^b   Van Lohuizen, Maarten ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; ONCOPROTEIN; PROTEIN BMI 1; UNCLASSIFIED DRUG; BMI1 PROTEIN, HUMAN; BMI1 PROTEIN, MOUSE; NUCLEAR PROTEIN; PROTEIN; PROTEIN P14ARF; PROTEIN P16INK4A; REPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; GENE ISOLATION; HOMEOBOX; HUMAN; HUMAN CELL; LYMPHOMA; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SENESCENCE; ANIMAL; CELL AGING; CELL CULTURE; CELL DIVISION; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; MOUSE MUTANT; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL AGING; CELL CYCLE; CELL DIVISION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FIBROBLASTS; GENE EXPRESSION REGULATION; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICE, KNOCKOUT; NUCLEAR PROTEINS; ONCOGENES; PROTEINS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 0033552813     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/16476     Document Type: Article

References (30)

1. van Lohuizen, M. et al. Identification of cooperating oncogens in Eμ-myc transgenic mice by provirus tagging. Cell 65, 735-732 (1991 ).
2. Haupt, Y., Alexander, W. S., Barri, G., Klinken, S. P. & Adams, J. M. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in Eμ-myc transgenic mice. Cell 65, 753-763 (1991).
3. van Lohuizen, M., Frasch, M., Wientjens, E. & Berns, A. Sequence similarity between the mammalian Bmi-1 proto-oncogene and the Drosophile regulatory genes Psc and Su(z)2. Nature 353, 353-355 (1991).
4. van der Lugt, N. M. T. et al. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the Bmi-1 proto-oncogene. Genes Dev., 8, 757-769 (1994).
5. Alkema, M. J. et al. MPc2, a new murine homologue of the Drosophila Polycomb protein is a member of the mouse Polycomb transcriptional repressor complex. J. Mol. Biol. 273, 993-1003 (1997).
6. Alkema, M. J., van der Lugt, N. M. T., Bobeldijk, R. C., Berns, A. & van Lohuizen, M. Transformation of axial skeleton due to overexpression of Bmi-1 in transgenic mice. Nature 374, 724-727 (1995).
7. Paro, R. Propagating memory of transcriptional states. Trends Genet. 11, 295-298 (1995).
8. van Lohuizen, M. Functional analysis of mouse Polycomb-group genes. Cell. Mol. Life Sci. 54, 71-79 (1998).
9. Gould, A. Functions of mammalian Polycomb group and trithorax group related genes. Curr Opin. Genet. Dev. 7, 488-494 (1997).
10. Alkema, M. J., Jacobs, H., van Lohuizen, M. & Berns, A. Perturbation of B and T cell development and predisposition to lymphomagenesis in Eμ,-Bmi1 transgenic mice require the Bmi1 RING finger. Oncogene 15, 899-910 (1997).
11. Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and aging skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363-9367 (1995).
12. Hara, E. et al. Regulation of p16 CDKN2 expression and its implications for cell immortalisation and senescence. Mol. Cell. Biol 16, 859-867 (1996).
13. Alcorta, D. A. et al. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts, Proc. Natl Acad Sci. USA 93, 13742-13747 (1996).
14. Zindy, F., Quelle, D. E., Roussel, M. F. & Sherr, C. J. Expression of the p16ink4a tumour suppressor versus other ink4 family members during development and aging. Oncogene 15, 203-211 (1997).
15. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16ink4a. Cell 88, 593-602 (1997).
16. Arf. Cell 91, 555-558 (1997).
17. Arf. Cell 91, 649-659 (1997).
18. Strutt, H., Cavalli, G. & Paro, R. Colocalisation of Polycomb protein and GAGA factor on regulatory elements responsible for the maintenance of homeotic gene expression, EMBO J. 12, 3621-3632 (1997).
19. Cavalli, G. & Paro, R. The Drosophila Fab-7 chromosomal dement conveys epigenetic inheritance during mitosis and meiosis. Cell 93, 505-518 (1998).
20. Pirotta, V. PcG complexes and chromatin silencing. Curr. Opin. Genet. Dev. 7, 249-258 (1997).
21. Alkema, M. J. et al. Identification of Bmi1-interacting proteins as constituents of a multimeric mammalian Polycomb complex Genes Dev. 11, 226-240 (1997).
22. Gunster, M. J. et al. Identification and characterisation of interactions between the vertebrate Polycomb-group protein BMI1 and the human homologues of Polyhomeotic. Mol. Cell Biol. 17, 2326-2335 (1997).
23. Akasaka, T. et al. A role for mel-18, a Polycomb group-related vertebrate gene, during the anteroposterior specification of the axial skeleton. Development 122, 1513-1522 (1996).
24. Serrano, M. et al. Role of the ink4a locus in tumour suppression and cell mortality. Cell 85, 27-37 (1996).
25. Zindy, F. et al. Myc signalling via the ARF tumour suppressor regulates p53-dependent apoptosis and immortalisation. Genes Dev. 12, 2424-2433 (1998).
26. ARF tumour suppressor. Genes Dev. 12, 2434-2442 (1998).
27. Blyth, K, et al. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss. Oncogene 10, 1717-1723 (1995).
28. Bodrug, S. E. et al. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBOS J. 13, 2124-2130 (1994).
29. Mateyak, M. K., Obaya, A. J., Adachi, S. & Sedivy, J. M. Phenotypes of c-Myc-deficient Rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ. 8, 1039-1048 (1997).
30. Hall, M. & Peters, G. Genetic alterations of cyclins, cyclin-dependent kinases and cdk inhibitors in human cancer. Adv. Cancer Res. 68, 67-108 (1996).